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The epidemiology of West Nile disease (WND) is influenced by multiple ecological factors and, therefore, integrated surveillance
systems are needed for early detecting the infection and activating consequent control actions. As different animal species have
different importance in the maintenance and in the spread of the infection, a multispecies surveillance approach is required. An
integrated and comprehensive surveillance system is in place in Italy aiming at early detecting the virus introduction,monitoring the
possible infection spread, and implementing preventivemeasures for humanhealth.This paper describes the integrated surveillance
system for WND in Italy, which incorporates data from veterinary and human side in order to evaluate the burden of infection in
animals and humans and provide the public health authorities at regional and national levels with the information needed for a fine
tune response.
1. Introduction
Theepidemiology of arboviral zoonoses is influenced bymul-
tiple ecological factors and, therefore, integrated and compre-
hensive surveillance systems are needed for early detecting
the infection and activating consequent control actions.West
Nile virus (WNV) is a Flavivirus belonging to the Japanese
encephalitis antigenic complex of the family Flaviviridae.
The genus Flavivirus also includes other arboviruses, such
as St Louis encephalitis virus, Japanese encephalitis virus,
Murray Valley virus, Usutu virus, and Kunjin virus. WNV is
maintained in nature by birds and is transmitted primarily by
the bite of infected mosquitoes acquiring the virus by feeding
on infected birds [1]. Mosquitoes can also acquire the virus
by transovarial transmission or by mating [2]. Migratory
birds are strongly suspected to play a significant role in
the introduction of WNV from endemic areas into new
regions [3]. Humans, horses and other mammals are consid-
ered incidental dead-end hosts [1].
West Nile disease (WND) is a zoonosis. The infection in
humans mainly occurs asymptomatically or with mild febrile
illness [4]. Less than 1% of patients show severe neurological
symptoms classifiable in three main syndromes: meningitis,
encephalitis, and poliomyelitis (acute flaccid paralysis) [5]. In
horses the disease is usually subclinical, although sometimes
they may show neurological symptoms [1].
In the Western Hemisphere WNV was first detected in
NewYorkCity in 1999 [6]. After that episode, the virus spread
dramatically westward across the United States of America,
southward into Central America and the Caribbean, and
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northward into Canada, resulting in the largest human
epidemic of a neuroinvasive disease ever reported [7].
The first large human outbreak of WND in Europe was
recorded in 1996 in Romania with 393 confirmed cases [8].
After that episode, the number of WND reported cases in
horses and humans increased significantly.This apparent rise
of reported cases is partly due to the improvement of both
surveillance systems and diagnostic methods [3, 9, 10], and
also to the introduction and rapid spread of WNV lineage 2
in Europe [11, 12]. In the last recent years, virus circulation
was observed in different Mediterranean countries with an
increasing number of human cases in the Eastern Europe [13].
Some countries (i.e., Greece, Spain, Russia, Israel, Hungary,
and Romania) were affected by the virus circulation for
several consecutive years, supporting the hypothesis of a
possible local endemisation of the infection.
As various animal host species take part, with different
epidemiological roles, to the transmission of WNV, a mul-
tispecies surveillance approach is required. Some European
countries focused their surveillance program only on human
population (i.e., Albania, Kosovo, Montenegro) [14], whereas
others integrated these activities with general and/or targeted
surveillance in equines (such as Croatia, Spain, Greece,
Portugal, France, Romania, Cyprus, and Morocco) [14–16].
Moreover, in some European nations (i.e., in Italy, Greece,
United Kingdom, Spain, Germany, Hungary, and Serbia)
the surveillance on mosquito populations is added to that
addressing humans and equines, with the aim of detecting
the WNV early during the season [11, 12, 17]. In this regard,
the highest percentage of mosquito pools tested positive for
WNV was reached in Serbia in 2013 (5.5%) [12].
In Italy, the first outbreak of WND was identified in
horses in Tuscany region during the late summer of 1998.
Fourteen animals showed neurological disorders [18], but no
cases of human encephalitis were reported [9]. Following this
epidemic, a national veterinary surveillance plan was put in
place in 2001 to identify the geographical areas at risk for
reintroduction of the WNV infection. This surveillance plan
was coordinated by the National Reference Centre for the
study of Exotic Animal Diseases (CESME) and carried out in
15 Italianwetlands. It was based on entomologicalmonitoring
and periodical serological testing of sentinel chickens and
equines [19, 20]. The surveillance system did not detect any
relevant circulation of WNV in animals until 2008, when
the virus was detected in mosquitoes, birds, equines, and
humans in the area surrounding the Po river delta, involving
eight provinces in three northern regions: Emilia Romagna,
Veneto, and Lombardy [20–22].
Based on what happened during 2008, the nationalWNV
veterinary surveillance system was revised and new activities
were added, aiming at identifying as early as possible the virus
circulation all over the country and implementing measures
for the prevention and control of human infections [20].
In light of the increasing number of confirmed cases
in animals and the circulation of the virus in a wider
geographical area, a human surveillance plan for the West
Nile neuroinvasive disease (WNND) was put in place in
2008 in Emilia Romagna and Veneto regions, which allowed
to detect the first eight indigenous cases of WNND in
humans [9].
In 2009, the results of the veterinary surveillance system
showed the resurgence of infection mostly in the same geo-
graphical areas of previous year, but new foci were reported in
central Italy, in Tuscany and Latium, rather far from the areas
infected in 2008 [22]. Cases of human WNND increased
to 18 in 2009 (nine cases in Emilia Romagna, seven in
Veneto, and two in Lombardy regions), occurring in the same
geographical areas where WNV circulation was detected in
mosquitoes and animals (chickens and equine) [9].
In August 2010, new foci of infection were observed
in Sicily and Molise regions, respectively, in southern and
central Italy. These outbreaks confirmed the WNV ability
of spreading to new areas, affecting new host populations
[20, 23]. In 2011, WND outbreaks were confirmed in six
regions: Sardinia, Sicily, Friuli Venetia Giulia, Veneto, Basili-
cata, and Calabria, where clinical cases in horses and neuro-
logical signs in birds were observed.
Between 2010 and 2011 seventeen new human cases of
WNND were reported from three regions (Veneto, Friuli
Venetia Giulia, and Sardinia) with a 23.5% case-fatality rate
[9].
Following the geographical spread of WNV westward,
the Directorate General for Prevention of the ItalianMinistry
of Health (MoH) issued on the spring of 2010, a national
plan for WNND human surveillance that integrated human
and veterinary surveillance [24]. Since then, the national
surveillance plan on imported and autochthonous human
vector-borne disease (chikungunya, dengue and West Nile
disease) was issued and revised annually [25–27].
In 2012 WNV continued to circulate in Italy causing
infection in humans, horses, birds, and vectors in Sardinia,
Friuli Venetia Giulia, Veneto, and Latium regions [10, 28, 29].
The main objective of this paper is to describe the
components of the integrated surveillance system for WNV
established in Italy with the aim of evaluating the burden
of the disease in animals and humans and providing the
Public Health local and national authorities with the needed
information to fine tune response. To this aim, the existing
data exchange flows between veterinary and human systems
and the results of 2013 surveillance are presented.
2. Materials and Methods
2.1. WNV Circulation Surveillance Plan in Animals. The
Italian national veterinary authority annually revises the
WNV veterinary surveillance plan in line with the observed
epidemiological changes. The surveillance plan for 2013
delimits three different geographical areas (Figure 1):
(i) with virus circulation (AVC): the geographic areas
affected by the circulation of WNV in the previous
years (since 2008),
(ii) surveillance zones (SZ): the territories surrounding
the AVC with an extension of 20 km,
(iii) at risk (AR): wetlands characterized by the presence
of a significant number of migratory water fowls.
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Figure 1: WND surveillance areas in 2013.
Target species of the veterinary surveillance activities include
migratory and resident birds, horses, and poultry. The ento-
mological surveillance is based on a certain number of
mosquito collection sites placed in the three abovementioned
areas for identifying possible WNV vector species and deter-
mining their abundance and spatiotemporal distributions
[30].
Active bird surveillance is focussed on the following
species: Magpie (Pica pica), Hooded Crow (Corvus corone
cornix), and Jay (Garrulus glandarius), which are sampled
and virologically tested inAVC. Serological testing of sentinel
chickens and backyard poultry is foreseen as a possible
alternative in case the planned activities on resident birds
could be not carried out. Passive surveillance on birds
mortality is carried out throughout the country, and target
species include Blackbird (Turdus merula), Starling (Sturnus
vulgaris), Jackdaw (Corvusmonedula),Magpie (Pica pica), Jay
(Garrulus glandarius), Hooded Crow (Corvus corone cornix),
and Collared dove (Streptopelia decaocto). In addition, any
episode of abnormal or increased mortality in other wild
birds must be reported to veterinary authorities.
Entomological surveillance aims at identifying the mos-
quito fauna, defining the composition of vector populations
and the species responsible for WNV transmission in the
enzootic and epizootic cycles of the disease, investigating
their ability to overwinter.
Moreover, countrywide passive surveillance on neurolog-
ical cases observed in equines is coupled with the serological
survey performed in sentinel horses three times per year (in
May, August, and September) in AR. In addition, when the
viral circulation is detected in zones not previously affected
by the infection, further activities are put in place to better
identify the extent of the infection.
2.2. Veterinary WND Surveillance Information System. In
2008, the Department of Veterinary Public Health Nutrition
and Food safety (VPH Department) of the MoH appointed
the CESME to develop an information system collecting data
on animal disease outbreaks, using standard procedures and
templates for data input and output [31].Thenew information
system, called SIMAN, was developed to provide a tool
for the management of epidemic emergencies, to collect
and communicate outbreak data to the MoH, the European
Commission and the World Organization of Animal Health
(OIE) in compliance with current national and international
legislation [32, 33]. SIMAN was firstly used by the veterinary
services during the large WND epidemic occurred in 2008.
The data reported to SIMAN allowed the veterinary services
to have the full picture of outbreaks distribution and to plan
further investigations [34].
Given the complex epidemiology of the disease and the
multidisciplinary approach needed for its surveillance, an
integrated and comprehensive system for the management of
WND outbreaks and surveillance activities was established.
In particular, new tools were developed in SIMAN for
(i) the registration of sentinel chickens and equines
into the National Database of livestock and holdings
(BDN);
(ii) recording and managing the laboratory results;
(iii) publishing weekly and daily reports describing the
outcomes of the surveillance activities.
A web-based geographic information system (WebGIS) was
also developed for displaying thematic maps and to help
the veterinary services to explore the area surrounding the
outbreak, to create buffers around the reported cases, and
to download the list of equine farms placed within the
buffers. An automatic procedure extracting every night all
data inconsistencies and errors assured the necessary quality
checks. In case of errors, an automatic alert email is sent
to the veterinary services asking for data verification and
correction.
2.3. WNND Surveillance Plan in Humans. The national
plan for human surveillance defines as “affected areas”
all the provinces (secondary administrative units) where
laboratory-confirmedWNV infections in animals, vectors, or
humans have been notified in the previous year or during
the current surveillance period (between 15 June and 30
November, as considered the period with the highest vector
activity). The identification of an affected area immediately
triggers the “surveillance area” that represents the regional
territory of the affected area [27].
In the affected area, local health authorities have to
implement an active surveillance system for WNND in
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workers employed in the farms where equine cases have
been identified and in individuals living or working in the
surrounding area (province). Moreover, the measures for
vector control have to be implemented immediately. At the
same time, passive surveillance on human neurological cases
has to be set up in the surveillance area, requesting physicians
to report all probable and confirmed WNND cases using a
modified European case definition [35]: a patient with fever
≥38.5∘C and neurological symptoms (encephalitis, meningi-
tis or Guillain-Barre´ syndrome or acute flaccid paralysis) and
at least one of the following laboratory criteria:
(i) for probable case: anti-WNV specific antibody
response in blood; Polimerase Chain Reaction (PCR)
positive in urine;
(ii) for confirmed case: viral isolation in blood or cere-
brospinal fluid (CSF); anti-WN IgM positive in CSF;
PCR positive in blood or CSF; confirmed presence of
anti-WN antibodies in blood by neutralization test.
The list of regional reference laboratories is also provided in
theWNND national surveillance plan.When a probable case
is reported, the regional reference laboratory has to proceed
for confirmation using one of the above reported laboratory
methods. In case the neutralisation test is not available at
the regional laboratory, patient’s sera are sent to the National
Reference Laboratory at Istituto Superiore di Sanita` (ISS) for
further confirmatory tests.
When WNND human cases are confirmed, immediate
WNV nucleic acid amplification test (NAAT) screening of
all blood and haematopoietic stem cells donations must
be ordered in the affected areas. Additional screening of
solid organ donations in surveillance areas (regions) are also
introduced [36]. At the national level, all blood, tissue and
solid organ donors who travelled to an affected area have to
be temporarily deferred for 28 days starting with the day they
left the affected area [37].
2.4. Case Reporting System of Human WNND. All human
cases are notified by regional authorities to the MoH and
to the Italian National Centre for Epidemiology, Surveil-
lance and Health Promotion (CNESPS-ISS) using a spe-
cific password-protected web-based system (http://www
.simi.iss.it/inserimento dati.htm), which permits to report
probable and confirmed cases, adding available epidemio-
logical, clinical and laboratory information. The database is
accessible also for the National Blood Centre and to the
National Transplant Network, which implements precaution-
ary measures on blood donation and transplant activities on
the basis of data on WNND human cases.
In addition to the activities foreseen by the national
WNND surveillance, an enhanced regional surveillance
for WNV fever (WNF) was established in Veneto, Emilia
Romagna, and Lombardy regions. The case definition for
WNF was the following: a person showing fever ≥38.5∘C (or
history of fever in the last 24 h) for a period no longer than
seven days, from 15 July to 30 November, with no recent
history of travels to tropical countries and absence of other
comorbidities accounting for the febrile illness.
All WNF confirmed cases are notified by the regional
authorities to the MoH and to the CNESPS-ISS through the
web-based system.
2.5. The Surveillance Systems Integration. During the vector
activity period, a data exchange protocol is in place between
SIMAN and the CNESPS-ISS to jointly define and update
the map of the affected areas (provinces). The identification
of new ACV and AE following the veterinary activities
immediately triggers the establishment of the “affected areas”
and the “surveillance areas” as foreseen by the humanWNND
surveillance plan. When an outbreak is confirmed in SIMAN
or a laboratory result confirms WNV circulation in a given
territory, measures for the prevention and control of the
infection in humans are immediately applied in the affected
areas. Veterinary and human surveillances are, therefore,
linked each other and work as a chain reaction.
Together with the animal and entomological monitoring,
the surveillance of WNND human cases allows to detect the
virus circulation in a given geographical area and to obtain an
estimation of its magnitude through the systematic detection
of emerging clinical cases.
The data flow in the web-based integrated surveillance
system is shown in Figure 2.
3. Results
3.1. Animal and Entomological Surveillance. In 2013, the
CESME confirmed 50 new cases of WND in equines, 12 of
which characterized by clinical signs, in Veneto, Lombardy,
Emilia Romagna, Calabria, Sardinia, and Sicily regions;
146 mosquito pools and 79 birds in Veneto, Lombardy,
Emilia Romagna, and Sardinia regions tested positive for
WNV PCR. The affected areas identified by the veterinary
monitoring activities were published on line (http://sorveg-
lianza.izs.it/emergenze/west nile/emergenze en.html).
3.2.WNNDHuman Surveillance. From 15 June to 30Novem-
ber 2013, 44 autochthonous human cases of WNND were
confirmed. The majority of patients were male (61.3%) with
a median age of 73 years (range: 42–89 years). The onset of
cases ranged between 21 July and 21 September: 75% had
the symptoms onset in August, which represented the peak
month in 2013 (Figure 3). None of the cases travelled abroad
during the incubation period.
The distribution of WNND confirmed cases by age and
region/province of exposure is showed inTable 1: themajority
ofWNND cases in 2013 were reported from Emilia Romagna
(20 cases) followed byVeneto (13 cases), Lombardy (10 cases),
and Apulia (1 case).
The majority of cases reported symptoms of encephalitis
(70.5%), followed by meningitis (38.6%), polyradiculoneuri-
tis (9.1%), and other neurological symptoms (18.2%). None
of the patients had history of vaccination against other
arboviruses. Seven cases died, corresponding to a 16.3% case
fatality rate.
From 15 June to 30 November, 34 confirmed cases of
WNF were also reported to the MoH and CNSPS-ISS by
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Figure 2: The web-based integrated surveillance system.
Table 1: WNND confirmed cases by region/province of exposure
and age group, Italy 2013.
Region/province Age Total
≤14 15–44 45–64 65–74 ≥75
Lombardy
Cremona 1 1
Mantua 2 2 2 6
Lodi 1 1
Brescia 2 2
Apulia
Foggia 1 1
Veneto
Rovigo 1 4 5
Treviso 3 1 4
Venice 2 2
Padua 1 1
Verona 1 1
Emilia-Romagna
Bologna 1 1
Ferrara 1 1 1 2 5
Modena 3 1 3 7
Parma 1 1
Reggio Emilia 1 5 6
Total 0 1 10 7 26 44
the public health authorities of Emilia Romagna (20 cases),
Veneto (13 cases), and Lombardy (1 case) regions.
During the surveillance period the CNESPS-ISS pub-
lished a weekly bulletin available in electronic format on the
website of the ISS (http://www.epicentro.iss.it).
3.3. Outcomes from the Integrated Surveillance System. Data
collected by both the veterinary and human surveillance sys-
tems in the previous year (2012) allowed to identify 9 regions
(surveillance areas) in which the WNV human surveillance
had to be performed in 2013 (Basilicata, Latium, Friuli Vene-
tia Giulia, Sardinia, Veneto, Emilia Romagna, Lombardy,
Calabria, and Sicily). Moreover, considering the geographical
characteristics of Basilicata, also its neighbouring region
(Apulia), although not directly affected, was included in the
surveillance areas as well. Figure 3 shows the ten Italian
Regions under surveillance.
During 2013 the veterinary surveillance activities con-
firmed the circulation of WNV in six regions (Sardinia,
Veneto, Emilia Romagna, Lombardy, Calabria, and Sicily), of
which three reported human cases (Veneto, Emilia Romagna,
and Lombardy). One human casewas reported also inApulia,
although no animals and vectors tested positive for WNV.
4. Discussion
The existence of surveillance systems able to represent an
early warning tool is pivotal for preventing the spread
of infectious diseases. The rapidity of the application of
appropriate control measures after the detection of an
emerging infectious/disease is crucial for the success of any
intervention.
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Apulia
Sicily
Emilia Romagna
Lazio
Lombardy
Calabria
Sardinia
Veneto
Friuli Venezia Giulia
Basilicata
Italian regions under surveillance for human WNND
Figure 3: Regions under surveillance for humanWNND, Italy 2013.
Between the first occurrence of WND in Italy in 1998
and its reemergence in 2008, WND was considered an exotic
disease for the Italian territory and the main objective of the
surveillance activities in place at that time was to evaluate the
possible reintroduction of the virus. In this context, the data
collected by the national system for the notification of animal
diseases (SIMAN) were useful for a rapid epidemiological
evaluation, to define areas at risk for human transmission
and to facilitate the implementation of effective and prompt
control measures.
In Italy the first WNND human cases were detected in
2008, when a human surveillance system was implemented
in the areas where the WNV circulation was demonstrated
among animals and vectors. Since then, human cases of
WNND have been reported every year in Italy, with a pick
of incidence in 2013 (44 confirmed cases). As shown in
Figure 4, the number of reported WNND human cases has
been recently increased, due to the greater attention to the
disease by the national authorities, and thanks to a better
integration of human and veterinary surveillance.
In fact, an early warning system for WNV detection,
based on animal and entomological surveillance, can provide
the basis for targeted public health interventions and risk
communication activities, aiming at reducing the risk of
human infection. Since the first occurrence of the virus the
multispecies surveillance plan in place in Italy was capable of
confirming the WNV ability of spreading to new geographi-
cal areas and infecting different host populations. Veterinary
surveillance activities, therefore, were particularly useful to
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Figure 4: WNND confirmed cases by date of symptoms onset, Italy
2008–2013.
assess and monitor the evolution of the epidemiological sit-
uation, providing the public health authorities with precious
and timely information onwhere andwhenWNDprevention
and control actions in humans had to be put in place. The
existence of an effective double way communication system
between veterinarian and human health authorities ensured
a prompt implementation of the preventive measures and a
more accurate assessment of the epidemiological situation
of the disease as well as a more precise estimation of the
extension of the infection.
Well-conducted veterinary surveillance program allowed
to identify the territories at major risk for WNV circulation
and to set up human surveillance activities in these geo-
graphical areas. It is noteworthy that some regions, where
WNV circulation was demonstrated in animal and vectors,
did not reported any human case. On the contrary, in
Apulia region, one autochthonous human case ofWNNDwas
confirmed in 2013, although no WND cases in horses or in
other animal species were reported, although the detection
three years before of a sporadic virus circulation in poultry
farms in a bordering territory highlighted the suitability
of that area for virus transmission. These findings confirm
the crucial role of an integrated human, animal and vector
surveillance in order to timely set up preventive measures. In
this context, the veterinary surveillance carried out in sentinel
animals, bird and vector populations can play a crucial role
for foreseeing human transmission, even considering the
limits of sensitivity of a surveillance system for vector-borne
diseases.
Entomological surveillance is also a central aspect, allow-
ing at early detecting the circulation of the virus [38–40].
In some provinces of northern Italy, the detection of WNV
circulation through entomological surveillance was as early
as July, largely more in advance than human cases occurrence
[38].
With regard to circulating viruses, in the last three years
WNV lineage 2was detected in several Italian foci, apparently
showing an extension of its spread and a more important
contribution played by this lineage in the overall epidemi-
ological situation in Italy. In addition, the co-circulation
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of lineages 1 and 2 in the same area [22] may create the
favourable conditions for possible changes in the virulence
of the viral strains, potentially leading to unexpected and
adverse consequences.
5. Conclusions
The integrated human and veterinary information systems
provide the Competent Authority with a large amount of
data and information on WNV circulation, thus, allowing
the evaluation of planned actions and, if needed, their
improvement or revision. In 2013, the integrated human,
entomological, and animal surveillance system was able to
monitor the spread ofWNV and supported the application of
controlmeasures for blood transfusions and organ donations,
preventing the transmission of the disease among human
population.
In conclusion, the Italian experience represents a good
example of collaboration among different sectors of public
health (human, veterinary, entomologists, and blood and
organ donation authorities) in a “one health” perspective [41].
Vector borne diseases, in fact, need a multidisciplinary and
integrated approach, that is more effective to assure animal
and human health, as well as the environment protection.
In case of zoonoses, such as WND, this approach is of
paramount importance for a better and holistic understand-
ing of the prevention of the diseases and the maintenance of
both human and animal health.
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